REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.48%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $71,913,487.25

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$637.36

▲ +1.53 (0.24%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Christopher R. Fenimore	CFO	Sell	5,680	$1,205.33	$6,846,274.40	15,305
8/7/2024	Jason Pitofsky	VP	Sell	487	$1,070.00	$521,090.00	4,204
7/11/2024	Joseph J. Larosa	EVP	Sell	1,866	$1,088.95	$2,031,980.70	37,937
7/1/2024	Arthur F. Ryan	Director	Sell	100	$1,059.24	$105,924.00	17,882
7/1/2024	Marion Mccourt	EVP	Sell	1,137	$1,047.11	$1,190,564.07	12,931
6/24/2024	Bonnie L. Bassler	Director	Sell	756	$1,062.00	$802,872.00	1,382
6/14/2024	Michael S. Brown	Director	Sell	1,535	$1,040.00	$1,596,400.00	1,382
6/11/2024	Leonard S. Schleifer	CEO	Sell	9,064	$1,015.43	$9,203,857.52	55,134
6/6/2024	Leonard S. Schleifer	CEO	Sell	787	$1,015.02	$798,820.74	64,198
6/5/2024	Bonnie L. Bassler	Director	Sell	827	$1,011.00	$836,097.00	1,382
5/28/2024	Michael S. Brown	Director	Sell	1,172	$974.86	$1,142,535.92	1,382
5/17/2024	Leonard S. Schleifer	CEO	Sell	22,830	$979.23	$22,355,820.90	466,877
5/14/2024	Leonard S. Schleifer	CEO	Sell	25,000	$979.25	$24,481,250.00	408,200
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644
4/11/2022	Robert E. Landry	CFO	Sell	1,862	$734.06	$1,366,819.72	28,744
4/8/2022	Robert E. Landry	CFO	Sell	325	$737.79	$239,781.75	28,744
4/7/2022	Bonnie L. Bassler	Director	Sell	1,240	$725.00	$899,000.00	1,082
4/7/2022	Joseph J. Larosa	EVP	Sell	5,114	$721.10	$3,687,705.40	16,900
4/5/2022	Leonard S. Schleifer	CEO	Sell	4,461	$710.05	$3,167,533.05	465,922
4/1/2022	Arthur F. Ryan	Director	Sell	100	$692.81	$69,281.00	22,282
4/1/2022	Marion Mccourt	EVP	Sell	1,000	$701.82	$701,820.00	22,014
4/1/2022	Robert E. Landry	CFO	Sell	316	$695.81	$219,875.96
3/31/2022	Leonard S. Schleifer	CEO	Sell	2,886	$710.01	$2,049,088.86	465,922
3/30/2022	Michael S. Brown	Director	Sell	408	$699.00	$285,192.00
3/29/2022	Robert E. Landry	CFO	Sell	2,683	$687.90	$1,845,635.70

See Full Table

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/19/2025	DSG Capital Advisors LLC	847	$0.60M	0.1%	N/A	0.001%
3/18/2025	111 Capital	531	$0.38M	0.1%	N/A	0.000%
3/17/2025	NorthCrest Asset Manangement LLC	11,346	$8.08M	0.2%	+2.4%	0.010%
3/14/2025	Lansforsakringar Fondforvaltning AB publ	41,633	$29.66M	0.4%	N/A	0.038%
3/13/2025	PKO Investment Management Joint Stock Co	10,800	$7.69M	1.0%	N/A	0.010%
3/12/2025	Centaurus Financial Inc.	196	$0.14M	0.0%	+63.3%	0.000%
3/4/2025	Siemens Fonds Invest GmbH	6,067	$4.26M	0.2%	+4.1%	0.006%
2/28/2025	Park Square Financial Group LLC	78	$56K	0.0%	N/A	0.000%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	178,590	$127.22M	0.3%	N/A	0.163%
2/27/2025	Pinnacle Wealth Planning Services Inc.	475	$0.34M	0.1%	-22.4%	0.000%
2/26/2025	Sculati Wealth Management LLC	1,953	$1.39M	0.5%	-1.9%	0.002%
2/25/2025	B. Riley Wealth Advisors Inc.	324	$0.23M	0.0%	-54.7%	0.000%
2/24/2025	United Advisor Group LLC	455	$0.32M	0.1%	-17.1%	0.000%
2/22/2025	American Trust	699	$0.50M	0.0%	+22.4%	0.001%
2/21/2025	Ascent Group LLC	387	$0.28M	0.0%	-17.7%	0.000%
2/21/2025	Putney Financial Group LLC	161	$0.12M	0.1%	N/A	0.000%
2/20/2025	Mackenzie Financial Corp	55,032	$39.20M	0.1%	-1.7%	0.050%
2/20/2025	Forum Financial Management LP	916	$0.65M	0.0%	+13.6%	0.001%
2/19/2025	Toronto Dominion Bank	60,005	$42.74M	0.1%	+9.7%	0.055%
2/19/2025	Formidable Asset Management LLC	919	$0.66M	0.1%	+16.6%	0.001%
2/19/2025	Cache Advisors LLC	3,860	$2.75M	1.0%	N/A	0.004%
2/19/2025	GF Fund Management CO. LTD.	31,042	$22.11M	0.5%	N/A	0.028%
2/19/2025	Pinney & Scofield Inc.	35	$25K	0.0%	N/A	0.000%
2/19/2025	Public Employees Retirement System of Ohio	47,140	$33.58M	0.1%	-19.2%	0.043%
2/18/2025	GTS Securities LLC	1,347	$0.96M	0.0%	-111.4%	0.001%
2/18/2025	Vise Technologies Inc.	786	$0.56M	0.0%	+69.8%	0.001%
2/18/2025	JT Stratford LLC	3,403	$2.42M	0.4%	+13.1%	0.003%
2/18/2025	Novem Group	1,038	$0.74M	0.1%	N/A	0.001%
2/18/2025	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	20,761	$14.79M	0.1%	+14.8%	0.019%
2/18/2025	CSS LLC IL	610	$0.44M	0.0%	N/A	0.001%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	982,064	$699.55M	0.2%	+30.1%	0.894%
2/17/2025	USS Investment Management Ltd	18,202	$12.97M	0.1%	-7.3%	0.017%
2/17/2025	Voloridge Investment Management LLC	212,128	$151.11M	0.5%	N/A	0.193%
2/17/2025	Waverly Advisors LLC	1,280	$0.91M	0.0%	+23.0%	0.001%
2/17/2025	Worldquant Millennium Advisors LLC	105,309	$75.02M	0.5%	-13.2%	0.096%
2/17/2025	Williams Jones Wealth Management LLC.	1,098	$0.78M	0.0%	-39.4%	0.001%
2/17/2025	Woodline Partners LP	103,279	$73.57M	0.5%	+3.9%	0.094%
2/17/2025	Zurich Insurance Group Ltd FI	23,784	$16.94M	0.1%	-62.6%	0.022%
2/17/2025	iSAM Funds UK Ltd	323	$0.23M	0.2%	-28.1%	0.000%
2/17/2025	Vestal Point Capital LP	20,000	$14.25M	0.8%	N/A	0.018%
2/17/2025	Victrix Investment Advisors	4,900	$3.49M	2.5%	N/A	0.004%
2/17/2025	Soleus Capital Management L.P.	2,300	$1.64M	0.1%	N/A	0.002%
2/17/2025	Vident Advisory LLC	4,677	$3.33M	0.1%	+228.7%	0.004%
2/17/2025	Westwood Holdings Group Inc.	12,024	$8.57M	0.1%	-0.7%	0.011%
2/17/2025	Triglav Skladi D.O.O.	2,515	$1.79M	0.1%	N/A	0.002%
2/17/2025	Twinbeech Capital LP	25,137	$17.91M	0.3%	-45.2%	0.023%
2/17/2025	Two Sigma Investments LP	34,543	$24.61M	0.1%	+54.3%	0.031%
2/17/2025	Tidal Investments LLC	7,715	$5.50M	0.0%	+21.5%	0.007%
2/17/2025	Teza Capital Management LLC	1,294	$0.92M	0.1%	+49.6%	0.001%
2/17/2025	Strive Asset Management LLC	588	$0.42M	0.3%	N/A	0.001%
2/17/2025	Tang Capital Management LLC	2,000	$1.43M	0.1%	N/A	0.002%
2/17/2025	Tema Etfs LLC	5,849	$4.17M	1.7%	N/A	0.005%
2/17/2025	Toronto Dominion Bank	60,005	$42.74M	0.1%	+9.7%	0.055%
2/17/2025	Scientech Research LLC	3,622	$2.58M	0.7%	+193.0%	0.003%
2/17/2025	Snowden Capital Advisors LLC	1,617	$1.15M	0.0%	+7.2%	0.001%
2/17/2025	Shell Asset Management Co.	11,331	$8.07M	0.4%	-2.0%	0.010%
2/17/2025	Sherbrooke Park Advisers LLC	2,004	$1.43M	0.5%	N/A	0.002%
2/17/2025	Sig Brokerage LP	1,064	$0.76M	0.0%	N/A	0.001%
2/17/2025	Royal Bank of Canada	288,937	$205.82M	0.0%	+10.5%	0.263%
2/17/2025	Rafferty Asset Management LLC	47,608	$33.91M	0.1%	+33.4%	0.043%
2/17/2025	Raiffeisen Bank International AG	4,995	$3.51M	0.1%	N/A	0.005%
2/17/2025	Polar Capital Holdings Plc	56,249	$40.07M	0.2%	-21.7%	0.051%
2/17/2025	ProShare Advisors LLC	146,135	$104.10M	0.2%	+21.7%	0.133%
2/17/2025	Quantinno Capital Management LP	5,031	$3.58M	0.0%	-32.7%	0.005%
2/17/2025	Pathstone Holdings LLC	13,677	$9.74M	0.0%	-8.4%	0.012%
2/17/2025	Mufg Securities Americas Inc.	1,554	$1.11M	0.1%	N/A	0.001%
2/17/2025	Man Group plc	36,144	$25.75M	0.1%	-40.3%	0.033%
2/17/2025	Nissay Asset Management Corp Japan ADV	24,125	$17.19M	0.1%	+3.6%	0.022%
2/17/2025	NorthRock Partners LLC	802	$0.57M	0.0%	+90.0%	0.001%
2/17/2025	Nuveen Asset Management LLC	475,630	$338.81M	0.1%	-30.7%	0.433%
2/17/2025	OMERS ADMINISTRATION Corp	4,979	$3.55M	0.0%	-23.9%	0.005%
2/17/2025	Morse Asset Management Inc	1,855	$1.32M	0.3%	-61.4%	0.002%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	82,519	$58.77M	0.1%	+2.1%	0.075%
2/17/2025	Mmbg Investment Advisors CO.	370	$0.26M	0.0%	N/A	0.000%
2/17/2025	Lazard Asset Management LLC	19,912	$14.18M	0.0%	+22.8%	0.018%
2/17/2025	LRI Investments LLC	48	$34K	0.0%	-72.6%	0.000%
2/17/2025	Laird Norton Wetherby Wealth Management LLC	2,326	$1.66M	0.1%	-6.6%	0.002%
2/17/2025	Lighthouse Investment Partners LLC	3,300	$2.35M	0.1%	N/A	0.003%
2/17/2025	Investment Management Corp of Ontario	5,149	$3.67M	0.1%	+43.5%	0.005%
2/17/2025	Jacobs Levy Equity Management Inc.	847	$0.60M	0.0%	-96.4%	0.001%
2/17/2025	Janus Henderson Group PLC	13,473	$9.60M	0.0%	-86.3%	0.012%
2/17/2025	Hudson Bay Capital Management LP	15,006	$10.69M	0.0%	-48.9%	0.014%
2/17/2025	Humankind Investments LLC	1,298	$0.93M	0.2%	+62.3%	0.001%
2/17/2025	Guardian Wealth Advisors LLC NC	397	$0.28M	0.0%	-3.6%	0.000%
2/17/2025	Gotham Asset Management LLC	11,423	$8.14M	0.1%	+103.0%	0.010%
2/17/2025	Graham Capital Management L.P.	1,506	$1.07M	0.0%	N/A	0.001%
2/17/2025	Focus Partners Wealth	9,184	$6.57M	0.0%	+209.1%	0.008%
2/17/2025	Forefront Analytics LLC	368	$0.26M	0.1%	+23.9%	0.000%
2/17/2025	Ellevest Inc.	542	$0.39M	0.0%	+59.4%	0.000%
2/17/2025	Ensign Peak Advisors Inc	41,649	$29.67M	0.1%	-2.6%	0.038%
2/17/2025	Ethic Inc.	10,668	$7.60M	0.2%	+73.2%	0.010%
2/17/2025	Fiduciary Trust Co	8,206	$5.85M	0.1%	-3.7%	0.007%
2/17/2025	FORA Capital LLC	2,553	$1.82M	0.2%	+115.6%	0.002%
2/17/2025	Family Management Corp	4,124	$2.94M	0.5%	+3.1%	0.004%
2/17/2025	Deutsche Bank AG	539,269	$384.14M	0.1%	+21.7%	0.491%
2/17/2025	DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main	10,562	$7.52M	0.0%	-74.4%	0.010%
2/17/2025	Dunhill Financial LLC	375	$0.27M	0.1%	+179.9%	0.000%
2/17/2025	EP Wealth Advisors LLC	1,246	$0.89M	0.0%	-15.1%	0.001%
2/17/2025	CoreCap Advisors LLC	266	$0.19M	0.0%	-90.9%	0.000%
2/17/2025	Crestline Management LP	2,789	$1.99M	0.1%	+259.4%	0.003%

Data available starting January 2016

See Full Table

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $637.36

$631.45

$642.97

50 Day Range

MA: $683.88

$634.14

$744.83

52 Week Range

Now: $637.36

$629.02

$1,211.20

Volume

805,912 shs

Average Volume

673,409 shs

Market Capitalization

$69.68 billion

P/E Ratio

16.65

Dividend Yield

0.13%

Beta

0.27

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Jason Pitofsky (VP)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Michael S Brown (Director)
Huda Y Zoghbi (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 8.45%
FMR LLC — 7.46%
Capital International Investors — 4.31%
Capital World Investors — 2.53%
Geode Capital Management LLC — 2.21%
Dodge & Cox — 2.11%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
FMR LLC
Capital World Investors
International Assets Investment Management LLC
Massachusetts Financial Services Co. MA
Invesco Ltd.
Wellington Management Group LLP
Nuveen Asset Management LLC
Legal & General Group Plc
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
Capital International Investors
Norges Bank
Price T Rowe Associates Inc. MD
Amundi
Loomis Sayles & Co. L P
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Proficio Capital Partners LLC
Voloridge Investment Management LLC